Previous studies have shown that silencing eIF3a is effective in suppressing cell proliferation and EMT in thyroid,13 liver,16 and pancreatic cancer.15 The present results support a role for eIF3a as an oncogene in CRC. Here, EIF3A is linked to familial pancreatic carcinoma.